HEC96719
HEC96719-P-02/CRC-C2028
Phase 1 small_molecule completed
Quick answer
HEC96719 for Nonalcoholic Steatohepatitis (NASH) is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Nonalcoholic Steatohepatitis (NASH)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed